---
title: "Vivos Therapeutics kantongi paten AS baru untuk teknologi perangkat oral Vivos CARE"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295580703.md"
description: "Vivos Therapeutics announced that the USPTO issued Patent No. 12,697,190 for its oral device with mandibular advancement technology. This is a continuation of Patent No. 12,048,608 (issued July 30, 2024), expanding patent protection for the Vivos CARE platform. The company holds two FDA 510(k) clearances for treating adult and pediatric obstructive sleep apnea (OSA). Management reports studies showing approximately 80% of patients achieve significant symptom reduction or resolution based on Apnea-Hypopnea Index scores."
datetime: "2026-08-11T21:06:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295580703.md)
  - [en](https://longbridge.com/en/news/295580703.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295580703.md)
generator: "portal-rs"
---

# Vivos Therapeutics kantongi paten AS baru untuk teknologi perangkat oral Vivos CARE

-   Vivos Therapeutics Inc. mengumumkan USPTO menerbitkan paten AS No. 12.697.190 untuk perangkat oral bergetar dengan kemajuan mandibula. \* Paten baru itu merupakan paten lanjutan dari paten AS No. 12.048.608 yang diterbitkan pada 30 Juli 2024. \* Perusahaan menilai kombinasi keduanya memperluas perlindungan paten atas platform perangkat medis oral Vivos CARE, dengan klaim lebih luas. \* Vivos CARE telah memperoleh dua 510(k) FDA pada 2023-2024 untuk OSA berat dewasa, OSA sedang-berat anak usia 6-17. \* Manajemen menyebut studi menunjukkan sekitar 80% pasien mencapai penurunan signifikan atau resolusi gejala OSA berdasarkan skor AHI. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vivos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-037173), on August 11, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [VVOS.US](https://longbridge.com/en/quote/VVOS.US.md)

## Related News & Research

- [Vivos Therapeutics issues new US patent broadening protection for Vivos CARE devices](https://longbridge.com/en/news/295581752.md)
- [Vivos Therapeutics opens Henderson, Nevada sleep testing and treatment center, targets over $10 million annual capacity](https://longbridge.com/en/news/296505979.md)
- [Vivos Therapeutics Reports Q2 2026 Results: Full Earnings Call Transcript](https://longbridge.com/en/news/295983640.md)
- [Vivos Therapeutics wins new US patent covering Vivos CARE oral device technology](https://longbridge.com/en/news/294968084.md)
- [Australia says Roblox hasn’t fixed its child predator problem](https://longbridge.com/en/news/296523838.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**